The Effect of Task-oriented EMG-triggered ES on Upper Limb Motor Function in Hemiplegic Cerebral Palsy

nihal tezel

Status: Completed

Conditions: Cerebral Palsy, Spastic

Treatments: Other: electromyography-triggered electrical stimulation

Study type: Observational

Funder types: Other

Identifiers

NCT04394819

DiskapiYBERHPTR

Details and patient eligibility

About

The purpose of our study; to investigate the effects of EMG-induced ES treatment on hand functions, muscle strength, and quality of life in patients with hemiplegic CP.

Full description

Upper limb spasticity greatly affects the hand functions of patients with cerebral palsy (CP) and impairs quality of life. The most important goal in rehabilitation; despite the existing deficiencies, the highest level of functional independence of the patient is to increase the quality of life. EMG-triggered biofeedback electrical stimulation (EMG-triggered-BF-ES) increases the patient's active participation and motivation in rehabilitation, creates visual or auditory BF, provides muscle reeducation, decreases spasticity, prevents atrophies and increases joint mobility and increases muscle functionality by increasing the patient's functionality. There are areas of use the EMG-triggered-BF-ES such as cerebrovascular disease (CVO), spinal cord injury, and CP. When the literature is examined; studies were found to be few, and no study evaluating the upper extremity was found in children with CP. The purpose of our study is the investigation of the effects of EMG-triggered-BF-ES treatment applied on hand functions, muscle strength, and quality of life in patients with CP.

Enrollment: 20 patients

Sex: All

Ages: 4 to 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• having a diagnosis of CP
• age between 4 and 18 year
• at least 10° of the active wrist and finger extension in the affected limb but less than normal
• upper limb spasticity (shoulder, elbow, wrist, and fingers) less than or equal to grade 2 according to the modified Ashworth scale (MAS)
• should be able to receive command

Exclusion criteria

• Mental retardation
• Passive range of motion (ROM) limitation in the upper extremity
• Sensory impairment in the upper extremity
• The visual and auditory deficit in the upper extremity
• MAS is more than 3.
• Botulinum toxin application to the upper limb in the last 6 months
• Any surgical application to the upper limb in the last 6 months

Trial design

20 participants in 1 patient group

experimental and control groups

Description:

Task-oriented EMG-triggered ES treatment will be applied to the experimental group 2 days a week for 5 weeks and will continue with conventional physiotherapy. The control group will only continue conventional physiotherapy treatment.

Treatment:

Other: electromyography-triggered electrical stimulation